HAUPPAUGE, N.Y., March 27, 2026 (GLOBE NEWSWIRE) — United-Guardian, Inc. (NASDAQ:UG) reported that net sales and net income for FY 2025 decreased compared to FY 2024. Net sales for the year decreased by 13% from $12,181,971 in 2024 to $10,545,468 in 2025, generating net income of $3,250,875 ($0.71 per share) in 2024 compared to $2,105,738 ($0.46 per share) in 2025. Donna Vigilante, President of United-Guardian, stated, “Our financial performance in 2025 was primarily impacted by the decrease in sales of our cosmetic ingredients. One of the issues we faced was excess inventory held by our largest cosmetic ingredient distributor, Ashland Specialty Ingredients (“ASI”). The inventory overstock led to reduced order quantities from ASI throughout the year. The situation was further impacted by decreased global demand for our products,...

Financial Statements as of Date of Filing Show Strong Improvements in Cash, Reduction in Accounts Payable, and a Cash Runway Through January 2028 Multiple Sclerosis Drug Candidate Lucid-21-302 Phase 1 Trial with Toxicology Studies Complete, and unbuzzd™ Clinical Trial Published in Peer-Reviewed Journal TORONTO, March 27, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum” or the “Company”), has reported its audited financial and operational results for the fourth quarter and year ended December 31, 2025. Fourth Quarter and Full Year 2025 Financial Results Quantum’s strong balance sheet and overall progress continue, and management is confident that there is sufficient working capital, as of the date of filing these Financial Statements, to carry out its operations over the next...

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading developer of the world’s largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today provided a corporate update and fourth quarter and full year financial results for the period ending December 31, 2025. Fourth Quarter and Full Year 2025 Financial HighlightsTotal cash of approximately $117.6 million at December 31, 2025 $11.4 million cash used in operations for the quarter ended December 31, 2025 Operating loss of $44.7 million, net loss of $40.4 million and net loss per share of $0.08 for the quarter ended December 31, 2025Exclusive Negotiations Underway for Nodule Processing & Refining Hub in Brownsville, TexasExclusive negotiations for 1,466 acres with...

SHOEMAKERSVILLE, Pa., March 27, 2026 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter vs. Prior Year Period:Net sales decreased to $25.1 million compared to $37.3 million. Gross Profit Margin increased to 8.5% of net sales compared to 4.9%. Adjusted Gross Profit Margin(1) increased to 15.4% of net sales compared to 9.6%. SG&A expense and Adjusted SG&A(1) expense decreased by 43.5% and 18.9%, respectively. Net loss increased to $242.2 million compared to $17.5 million. Net loss in the fourth quarter of 2025 included a non-cash...

Revenue growth driven by expanding Builder+ block-building activity, with Imperium delivering $1.3 million in revenue following its Q3’25 launch WAYNE, Pa., March 27, 2026 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), short for Blockchain Technology Consensus Solutions, a company focused on blockchain infrastructure and decentralized finance operations, today announced its financial results for the year ended December 31, 2025 (“FY 2025”). The Company also released an updated investor presentation available at www.btcs.com/investors/. “2025 was a transformative year for BTCS as we scaled our Ethereum-first operating model and delivered record revenue,” said Charles Allen, Chief Executive Officer of BTCS. “Revenue grew over 300%, driven by the expansion of Builder+, our block-building business, and the successful...

~ Q4 2025 Delivers Strongest Revenue Quarter of the Year ~ ~ Debt-Free Balance Sheet and $14M in Year-End Cash Enable Focus on Execution ~ ~ Diversified Revenue and Shift to Scalable Offerings Support Path to Profitable Future ~ SANTA MONICA, March 27, 2026 (GLOBE NEWSWIRE) —  Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company that generates revenue by executing interactive advertising and immersive content programs for brands seeking to reach and influence people who play video games, today released fourth quarter and full year 2025 financial results. Super League Chief Executive Officer, Matt Edelman Commented: “Super League is a fundamentally different company than it was a year ago. We have a stronger foundation and a clearer path to scale, positioned to help brands reach and influence...

– Fourth quarter revenue of $2.4 million, up 8.7% sequentially and 19.2% year-over-year TAMPA, Fla., March 27, 2026 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today reported financial results for the three and twelve months ended December 31, 2025. Fourth Quarter 2025 Financial HighlightsTotal revenue for the fourth quarter ended December 31, 2025 was $2.4 million dollars, up 8.7% sequentially from Q3 2025 and 19.2% for the quarter year-over-year. The sequential increase reflects higher Bitcoin production but partial offset by a lower average Bitcoin price. The Company mined 22.0 Bitcoin during the fourth quarter 2025 at an average price of approximately $99,700, compared to 17.6 Bitcoin in Q3 2025 at an average Bitcoin value of approximately...

– Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year –  – Purchase commitment received for a minimum of $1.475 million for a clinical evaluation and outreach program in the Kingdom of Saudi Arabia – – Submitted of a Marketing Authorization Application with the Israel Ministry of Health – – U.S. Department of Defense authorized funding for procurement of bioengineered blood vessels – – Major milestone upcoming: Top-line interim result from V012 Phase 3 study in hemodialysis access – – Conference call today at 8:00 am ET – DURHAM, N.C., March 27, 2026 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered...

Completed a US$57.2 million equity financing; commenced trading on the Nasdaq Global Market under the ticker “MSLE” on Feb. 6, 2026Secured global regulatory clearances and initiated BASECAMP, a placebo-controlled Phase 2 clinical trial of SAT-3247 in boys aged 7 to less than 10 years living with Duchenne muscular dystrophy (“Duchenne” or “DMD”)Presented initial functional outcomes from 56 days of treatment in TRAILHEAD (follow-on trial to CL-101) at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, demonstrating that grip strength improvements observed in CL-101 were maintained or improved in TRAILHEAD over an aggregate period of 9 to 13 monthsReported proteomic data from CL-101 (28-day Phase 1b trial in adults with DMD) at MDA, showing reductions in established biomarkers of muscle degeneration...

Record Quarterly Revenues of $737.6 Million, a 34.6% Increase from a Year Ago Quarterly Adjusted EBITDA (non-GAAP) Increased 53% from Prior Year1 Record Total Backlog and Awards of $3.7 Billion, 49% Increase from a Year Ago, with Robust Q4 Book-to-Bill of 1.9x Tuck-In Acquisition of Seattle Area-Based Engineering Firm Establish First Quarter 2026 Guidance for Revenue of $925 Million – $950 Million and Non-GAAP Adjusted EBITDA of $90 Million – $100 Million Raise Full Year 2026 Guidance for Revenue to $3.7 Billion – $3.9 Billion and Non-GAAP Adjusted EBITDA of $400 Million – $430 Million SAN JOSE, Calif., March 27, 2026 (GLOBE NEWSWIRE) — Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today reported financial results for the fourth quarter and year ended December 31, 2025. “Our fourth quarter 2025...